advertisement
advertisement

CVS is coming out with a much cheaper generic version of EpiPen

CVS said today it’s planning to sell a generic EpiPen competitor at a fraction of the price. Under pressure from lawmakers and the public last year, Mylan announced a generic version of the life-saving auto-injector at a list price of $300. CVS Health says its version will sell for only $110. That’s down significantly from the … Continue reading “CVS is coming out with a much cheaper generic version of EpiPen”

CVS said today it’s planning to sell a generic EpiPen competitor at a fraction of the price. Under pressure from lawmakers and the public last year, Mylan announced a generic version of the life-saving auto-injector at a list price of $300. CVS Health says its version will sell for only $110. That’s down significantly from the $600 Mylan had been charging. USA Today has more about the announcement.

advertisement
advertisement
advertisement

About the author

Christopher Zara is a senior staff news editor for Fast Company and obsessed with media, technology, business, culture, and theater. Before coming to FastCo News, he was a deputy editor at International Business Times, a theater critic for Newsweek, and managing editor of Show Business magazine

More